Prevention & Treatment Archives

February 16, 2022

Dr. Leyfman Discusses the Increased risk of COVID-19 and Cancer Patients

Dr. Leyfman discusses three medications that he hopes will prove to help with COVID-19

February 16, 2022

Cancer and COVID-19: A Proposed Mechanism with Therapeutic Interventions

In our second interview, Dr. Leyfman shared his research on COVID-19 and cancer patients presented at the American Society of Clinical Oncology’s Annual Meeting or ASCO 2021. He discussed a radically different approach with an experimental cellular therapy, mesenchymal stem cells, which demonstrated a 91% overall survival and 100%

February 16, 2022

ASH 2021: A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients

This abstract from the American Society of Hematology Annual Meeting and Exposition (ASH 2021) reported analysis of retrospective data from 91 adult patients in France with lymphoma or chronic lymphocytic leukemia (CLL) who enrolled in a study of antibody responses, measured two or more weeks after receiving second or

February 7, 2022

Vitamin D-Deficiency and Covid

The chances are strong that you are Vitamin D deficient. If you are, you’re not alone. Vitamin D deficiency is a significant public health problem worldwide, irrespective of geography.

January 28, 2022

Dr. Saltzman: Some Good News on Response to a Third Dose of SARS-CoV-2 mMRA Vaccines in CLL/SLL Patients and Others with Blood Cancers

LLS (Leukemia and Lymphoma Society) has been doing extensive longitudinal research led by Dr. Larry Saltzman on blood cancer patients’ responses to SARS-CoV-2 vaccines.

January 25, 2022

Pandemic Mental Health for the Immunosuppressed

Those of us who are immunosuppressed usually focus, appropriately, our energy and time on the many challenges relating to maintaining our physical health.

January 13, 2022

January 2022: Dr. Sameer Parikh on COVID-19 State of Affairs for Those with CLL/SLL

In the first half of January 2022, Dr. Sameer Parikh from Mayo, Rochester, MN, discusses the present state of affairs related to COVID-19 for those with chronic lymphocytic leukemia/small lymphocytic lymphoma or CLL/SLL.

January 10, 2022

COVID-19: Dr. Sameer Parikh on Drug Interactions Between Paxlovid and CLL/SLL Drugs

Paxlovid (nirmatrelvir co-packaged with ritonavir) was recently issued an Emergency Use Authorization (EUA) for the treatment of mild-to-moderate COVID-19 in those at high risk to progress to more severe disease, such as those with chronic lymphocytic leukemia/small lymphocytic lymphoma or CLL/SLL.

January 7, 2022

COVID-19 Public Therapeutic Locator: An Important New Resource for Those with CLL/SLL

We all know that there are significant shortages of the potentially lifesaving medications for treatment and prevention of COVID-19 infections in the immunocompromised, including those with chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL).

Prevention & Treatment

Dr. Leyfman Discusses the Increased risk of COVID-19 and Cancer Patients

Cancer and COVID-19: A Proposed Mechanism with Therapeutic Interventions

ASH 2021: A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients

Vitamin D-Deficiency and Covid

Dr. Saltzman: Some Good News on Response to a Third Dose of SARS-CoV-2 mMRA Vaccines in CLL/SLL Patients and Others with Blood Cancers

Pandemic Mental Health for the Immunosuppressed

January 2022: Dr. Sameer Parikh on COVID-19 State of Affairs for Those with CLL/SLL

COVID-19: Dr. Sameer Parikh on Drug Interactions Between Paxlovid and CLL/SLL Drugs

COVID-19 Public Therapeutic Locator: An Important New Resource for Those with CLL/SLL

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT